ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Tuesday, 17 November 2026 NSE & BSE filings, as they land
ALFA News Straight from the exchange filing
Partnership

Star Imaging and Path Lab Signs MoU with BSES Yamuna Power for Diagnostic Services

Star Imaging and Path Lab Limited has entered into a Memorandum of Understanding with BSES Yamuna Power Limited to serve as a designated diagnostic centre. The partnership enables the provision of radiology and pathology services to BSES Yamuna Power's workforce and their dependents through December 2027.

Close-up view of a modern CT scanner in a healthcare facility. Stock photo illustrating Star Imaging and Path Lab's partnership story.
Photo: MART PRODUCTION / Pexels
Key numbers
Market Cap ₹110.44 CrHealthcare Services
P/E TTM 5.73Sector PE 56.58
Promoter Holding 71.92%Latest Quarter
1-Year Return -54.02%Price Performance
Execution periodValid up to 31 December 2027

Key highlights

  • MoU signed with BSES Yamuna Power Limited (BYPL) for designated diagnostic centre status
  • Scope includes pathology and radiology diagnostic services for employees and family members
  • Agreement remains valid until December 31, 2027
  • Services to be provided at prevailing CGHS rates on both credit and cash basis
  • Company currently operates with a market capitalization of ₹110.44 crore

Diagnostic Empanelment and Service Scope

Star Imaging and Path Lab Limited formally announced the execution of a Memorandum of Understanding (MoU) with BSES Yamuna Power Limited (BYPL) on November 17, 2026. Under this arrangement, the company will act as a designated diagnostic centre, providing a comprehensive suite of pathology and radiology services. The agreement specifically caters to BYPL employees, their eligible dependent family members, and other designated beneficiaries.

The MoU is structured to remain in effect until December 31, 2027, with services priced according to prevailing Central Government Health Scheme (CGHS) rates. This partnership is expected to bolster the company's network and diversify its institutional client base.

Strategic Growth Through Institutional Tie-ups

  • Secured diagnostic empanelment with the Municipal Corporation of Delhi (MCD) on October 12, 2026
  • Entered diagnostic services agreement with Delhi High Court on January 21, 2026
  • Signed empanelment MoUs with Bureau of Indian Standards and IPGCL in February 2026
  • Commissioning of the new Dwarka diagnostic centre scheduled for end-November 2026
  • Ongoing execution of three advanced diagnostic projects involving MRI and CT modalities
  • Strategic focus on credit-based institutional services at standard government-prescribed rates

Financial Performance and Market Position

The company reported an annual net profit of ₹19.28 crore for the year ending March 2026, representing a year-on-year growth of 21.06%. While the stock has experienced significant volatility with a one-year price decline of 54.02%, its valuation metrics remain distinct within the healthcare services sector. Specifically, the company's price-to-earnings (P/E) ratio stands at 5.73, compared to the industry average of 44.94.

With a high promoter holding of 71.92% and zero reported pledges, the company maintains a stable ownership structure as it prepares for its H1 FY27 earnings call scheduled for November 18, 2026.

Star Imaging And Path Lab · share price, past month
Earlier announcements by Star Imaging And Path Lab
DateAnnouncementAmount
12 Oct 2026Empanelment agreement with Municipal Corporation of Delhi (MCD) to provide diagnostic services at CGHS prescribed ratesSource: scanx.trade–
09 Feb 2026Empanelment agreement with Bureau of Indian Standards (BIS) and Indraprastha Power Generation Company Limited (IPGCL) for diagnostic servicesSource: shreni.in–
22 Jan 2026Empanelment agreement with National Institute of Educational Planning and Administration (NIEPA) for medical diagnostic and laboratory servicesSource: economictimes.indiatimes.com–
21 Jan 2026Agreement with High Court of Delhi to provide credit and cashless medical diagnostic servicesSource: scanx.trade–
14 Jan 2026Empanelment agreement with Central Electricity Regulatory Commission (CERC) for medical diagnostic and laboratory servicesSource: scanx.trade–
13 Jan 2026Empanelment agreement with Indian Council of Social Science Research (ICSSR), Ministry of Education, for diagnostic servicesSource: shreni.in–

What to watch next

  • H1 FY27 earnings conference call scheduled for November 18, 2026
  • Operational commissioning of the Dwarka diagnostic centre by late November 2026
  • Progress on three advanced diagnostic projects featuring high-end imaging technology
Star Imaging And Path Lab · financial snapshot
Share price₹63.4
Market capitalisation₹110.44 Cr
Revenue (annual)₹88.53 Cr
Net profit (annual)₹19.28 Cr
P/E (TTM)5.73×Sector 56.58×
Promoter holding71.92%
FII holding0.06%Current quarter

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.

Source verified

Exchange filing by Star Imaging and Path Lab Limited regarding the execution of an MoU with BSES Yamuna Power Limited. Market figures from a third-party data provider.

Read the filing ↗
All Star Imaging And Path Lab filings and newsView all → Every Star Imaging And Path Lab announcement on ALFA FilingsSee filings →

More from Star Imaging And Path Lab

All →

More in Partnerships

All →